Inaperisone

Inaperisone
Inaperisone_skeletal.svg
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Inaperisone is a muscle relaxant used in the treatment of muscle spasticity and other conditions involving excessive muscle tension. It is known for its ability to alleviate muscle stiffness and improve mobility in patients with various neuromuscular disorders.

Mechanism of Action

Inaperisone works by acting on the central nervous system to reduce muscle tone. It is believed to inhibit the transmission of nerve impulses in the spinal cord, thereby decreasing the excitability of motor neurons. This leads to a reduction in muscle spasm and an increase in muscle relaxation.

Pharmacokinetics

The absorption, distribution, metabolism, and excretion of inaperisone are important for understanding its clinical effects. After oral administration, inaperisone is absorbed into the bloodstream and distributed throughout the body. It is metabolized primarily in the liver and excreted via the kidneys.

Clinical Uses

Inaperisone is primarily used to treat conditions associated with muscle spasticity, such as:

• Multiple sclerosis
• Cerebral palsy
• Spinal cord injury
• Stroke

Side Effects

Common side effects of inaperisone include:

• Drowsiness
• Dizziness
• Nausea
• Headache

Less common but more serious side effects may include allergic reactions and liver dysfunction.

Contraindications

Inaperisone should not be used in patients with known hypersensitivity to the drug. Caution is advised in patients with liver disease or renal impairment.

Related pages

• Muscle relaxant
• Spasticity
• Central nervous system

Inaperisone

• 
  Inaperisone skeletal structure